Venge P - Search Results

1

High-Sensitivity Cardiac Troponin I Is a Strong Predictor of Cardiovascular Events and Mortality in the AGES-Reykjavik Community-Based Cohort of Older Individuals.

Thorsteinsdottir I, Aspelund T, Gudmundsson E, Eiriksdottir G, Harris TB, Launer LJ, Gudnason V, Venge P. Thorsteinsdottir I, et al. Among authors: venge p. Clin Chem. 2016 Apr;62(4):623-30. doi: 10.1373/clinchem.2015.250811. Epub 2016 Mar 2. Clin Chem. 2016. PMID: 26936931 Free PMC article.

2

Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group.

Lindahl B, Venge P, Wallentin L. Lindahl B, et al. Among authors: venge p. Circulation. 1996 May 1;93(9):1651-7. doi: 10.1161/01.cir.93.9.1651. Circulation. 1996. PMID: 8653870 Clinical Trial.

3

Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group.

Lindahl B, Andrén B, Ohlsson J, Venge P, Wallentin L. Lindahl B, et al. Among authors: venge p. Eur Heart J. 1997 May;18(5):762-70. doi: 10.1093/oxfordjournals.eurheartj.a015341. Eur Heart J. 1997. PMID: 9152646 Clinical Trial.

4

New generation cardiac troponin I assay for the access immunoassay system.

Venge P, Lindahl B, Wallentin L. Venge P, et al. Clin Chem. 2001 May;47(5):959-61. Clin Chem. 2001. PMID: 11325911 No abstract available.

5

Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy).

Venge P, Lagerqvist Bo, Diderholm E, Lindahl B, Wallentin L. Venge P, et al. Am J Cardiol. 2002 May 1;89(9):1035-41. doi: 10.1016/s0002-9149(02)02271-3. Am J Cardiol. 2002. PMID: 11988191 Clinical Trial.

6

Multicenter evaluation of an automated assay for troponin I.

Uettwiller-Geiger D, Wu AH, Apple FS, Jevans AW, Venge P, Olson MD, Darte C, Woodrum DL, Roberts S, Chan S. Uettwiller-Geiger D, et al. Among authors: venge p. Clin Chem. 2002 Jun;48(6 Pt 1):869-76. Clin Chem. 2002. PMID: 12029002

7

Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy.

Venge P, Johnston N, Lagerqvist B, Wallentin L, Lindahl B; FRISC-II Study Group. Venge P, et al. Clin Chem. 2003 Jun;49(6 Pt 1):880-6. doi: 10.1373/49.6.880. Clin Chem. 2003. PMID: 12765983 Clinical Trial.

8

Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study.

Zethelius B, Johnston N, Venge P. Zethelius B, et al. Among authors: venge p. Circulation. 2006 Feb 28;113(8):1071-8. doi: 10.1161/CIRCULATIONAHA.105.570762. Epub 2006 Feb 20. Circulation. 2006. PMID: 16490824

9

The antibody configurations of cardiac troponin I assays may determine their clinical performance.

James S, Flodin M, Johnston N, Lindahl B, Venge P. James S, et al. Among authors: venge p. Clin Chem. 2006 May;52(5):832-7. doi: 10.1373/clinchem.2005.064857. Epub 2006 Mar 16. Clin Chem. 2006. PMID: 16543388

10

Clinical performance of two highly sensitive cardiac troponin I assays.

Venge P, James S, Jansson L, Lindahl B. Venge P, et al. Clin Chem. 2009 Jan;55(1):109-16. doi: 10.1373/clinchem.2008.106500. Epub 2008 Nov 6. Clin Chem. 2009. PMID: 18988756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters